Microplate Dx

Glasgow-based medical start-up Microplate Dx has successfully closed a £2.5 million seed funding round to accelerate the development of its point-of-care diagnostic platform. The technology aims to combat antimicrobial resistance (AMR) by quickly identifying the most effective antibiotics for